The epidemiology of carbapenemases in Latin America and the Caribbean

References

• Bush K, Jacoby GA. Updated functional classification of β-lactamases. Antimicrob Agents Chemother. 2010;54(3):969–976.
   PubMed Web of Science ®Google Scholar
• Patel G, Bonomo RA. “Stormy waters ahead”: global emergence of carbapenemases. Front Microbiol. 2013;4:48.
   PubMed Web of Science ®Google Scholar
• Tzouvelekis LS, Markogiannakis A, Psichogiou M, et al. Carbapenemases in klebsiella pneumoniae and other enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev. 2012;25(4):682–707.
   PubMed Web of Science ®Google Scholar
• Falagas ME, Tansarli GS, Karageorgopoulos DE, et al. Deaths attributable to carbapenem-resistant enterobacteriaceae infections. Emerg Infect Dis. 2014;20(7):1170–1175.
   PubMed Web of Science ®Google Scholar
• Villegas MV, Pallares CJ, Escandón-Vargas K, et al. Characterization and clinical impact of bloodstream infection caused by carbapenemase-producing enterobacteriaceae in seven Latin American countries. Plos One. 2016;11(4):e0154092.
   PubMed Web of Science ®Google Scholar
• Hernández-Gómez C, Motoa G, Pallares C, et al. Economic impact of carbapenemase-producing Enterobacteriaceae causing bloodstream infections in Latin America. Open Forum Infect Dis. 2015;2(Suppl 1):S447.
   Google Scholar
• Nordmann P, Mariotte S, Naas T, et al. Biochemical properties of a carbapenem-hydrolyzing β-lactamase from enterobacter cloacae and cloning of the gene into escherichia coli. Antimicrob Agents Chemother. 1993;37(5):939–946.
   PubMed Web of Science ®Google Scholar
• Naas T, Nordmann P. Analysis of a carbapenem-hydrolyzing class A β-lactamase from enterobacter cloacae and of its LysR-type regulatory protein. Proc Natl Acad Sci U S A. 1994;91(16):7693–7697.
   PubMed Web of Science ®Google Scholar
• Pottumarthy S, Moland ES, Juretschko S, et al. NmcA carbapenem-hydrolyzing enzyme in enterobacter cloacae in North America. Emerg Infect Dis. 2003;9(8):999–1002.
   PubMed Web of Science ®Google Scholar
• Deshpande LM, Jones RN, Fritsche TR, et al. Occurrence and characterization of carbapenemase-producing enterobacteriaceae: report from the SENTRY antimicrobial surveillance program (2000-2004). Microb Drug Resist. 2006;12(4):223–230.
   PubMed Web of Science ®Google Scholar
• Radice M, Power P, Gutkind G, et al. First class A carbapenemase isolated from enterobacteriaceae in Argentina. Antimicrob Agents Chemother. 2004;48(3):1068–1069.
   PubMed Web of Science ®Google Scholar
• Blanco VM, Rojas LJ, De La Cadena E, et al. First report of a nonmetallocarbapenemase class A carbapenemase in an enterobacter cloacae isolate from Colombia. Antimicrob Agents Chemother. 2013;57(7):3457.
   PubMed Web of Science ®Google Scholar
• Cuzon G, Naas T, Truong H, et al. Worldwide diversity of klebsiella pneumoniae that produces β-lactamase blaKPC-2 gene. Emerg Infect Dis. 2010;16(9):1349–1356.
   PubMed Web of Science ®Google Scholar
• Yu W-L, Lee M-F, Tang H-J, et al. Emergence of KPC new variants (KPC-16 and KPC-17) and ongoing outbreak in southern Taiwan. Clin Microbiol Infect. 2015;21(4):347.e5-8.
   Google Scholar
• Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45(4):1151–1161.
   PubMed Web of Science ®Google Scholar
• Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13(9):785–796.
   PubMed Web of Science ®Google Scholar
• Villegas MV, Lolans K, Correa A, et al. First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of klebsiella pneumoniae from South America. Antimicrob Agents Chemother. 2006;50(8):2880–2882.
   PubMed Web of Science ®Google Scholar
• Villegas MV, Lolans K, Correa A, et al. First identification of pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing β-lactamase. Antimicrob Agents Chemother. 2007;51(4):1553–1555.
   PubMed Web of Science ®Google Scholar
• Lopez JA, Correa A, Navon- Venezia S, et al. Intercontinental spread from Israel to Colombia of a KPC-3- producing klebsiella pneumoniae strain. Clin Microbiol Infect. 2011;17(1):52–56.
   PubMed Web of Science ®Google Scholar
• Navon-Venezia S, Leavitt A, Schwaber MJ, et al. First report on a hyperepidemic clone of KPC-3-producing klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States. Antimicrob Agents Chemother. 2009;53(2):818–820.
   PubMed Web of Science ®Google Scholar
• Cuzon G, Naas T, Correa A, et al. Dissemination of the KPC-2 carbapenemase in non-klebsiella pneumoniae enterobacterial isolates from Colombia. Int J Antimicrob Agents. 2013;42(1):59–62.
   PubMed Web of Science ®Google Scholar
• Cuervo SI, Sánchez R, Gómez-Rincón JC, et al. Behavior of carbapenemase-producing klebsiella pneumoniae cases in cancer patients at a third level hospital in Bogotá, D.C. Biomedica. 2014;34(Suppl 1):170–180.
   PubMed Web of Science ®Google Scholar
• Martinez P, Sanchez L, Mattar S. Carbapenemase KPC-2 in ESBL-producing enterobacteriaceae from two clinics from Villavicencio, Colombia. Braz J Infect Dis. 2014;18(1):100–101.
   PubMed Web of Science ®Google Scholar
• Rodríguez EC, Saavedra SY, Leal AL, et al. The spread of KPC-3 klebsiella pneumoniae in hospitals in Bogotá over a three-year period (2008-2010). Biomedica. 2014;34(Suppl 1):224–231.
   PubMed Web of Science ®Google Scholar
• Pacheco R, Osorio L, Correa AM, et al. Prevalence of gram-negative bacteria harboring bla KPC gene in Colombian hospitals. Biomedica. 2014;34(Suppl 1):81–90.
   PubMed Web of Science ®Google Scholar
• Vanegas JM, Parra OL, Jiménez JN. Molecular epidemiology of carbapenem resistant gram-negative bacilli from infected pediatric population in tertiary-care hospitals in Medellín, Colombia: an increasing problem. BMC Infect Dis. 2016;16(1):463.
   PubMed Web of Science ®Google Scholar
• Mojica MF, Correa A, Vargas DA, et al. Molecular correlates of the spread of KPC-producing enterobacteriaceae in Colombia. Int J Antimicrob Agents. 2012;40(3):277–279.
   PubMed Web of Science ®Google Scholar
• Ocampo AM, Chen L, Cienfuegos AV, et al. A two-year surveillance in five Colombian tertiary care hospitals reveals high frequency of non-CG258 clones of carbapenem-resistant klebsiella pneumoniae with distinct clinical characteristics. Antimicrob Agents Chemother. 2016;60(1):332–342.
   Web of Science ®Google Scholar
• Pavez M, Mamizuka EM, Lincopan N. Early dissemination of KPC-2-producing klebsiella pneumoniae strains in Brazil. Antimicrob Agents Chemother. 2009;53(6):2702.
   PubMed Web of Science ®Google Scholar
• Zavascki AP, Zoccoli CM, Machado ABMP, et al. KPC-2-producing klebsiella pneumoniae in Brazil: a widespread threat in waiting? Int J Infect Dis. 2010;14(6):e539–40.
   PubMed Web of Science ®Google Scholar
• Monteiro J, Santos AF, Asensi MD, et al. First report of KPC-2-producing klebsiella pneumoniae strains in Brazil. Antimicrob Agents Chemother. 2009;53(1):333–334.
   PubMed Web of Science ®Google Scholar
• Peirano G, Seki LM, Val Passos VL, et al. Carbapenem-hydrolysing β-lactamase KPC-2 in klebsiella pneumoniae isolated in Rio de Janeiro, Brazil. J Antimicrob Chemother. 2009;63(2):265–268.
   PubMed Web of Science ®Google Scholar
• Zavascki AP, Machado ABMP, De Oliveira KRP, et al. KPC-2-producing enterobacter cloacae in two cities from Southern Brazil. Int J Antimicrob Agents. 2009;34(3):286–288.
   PubMed Web of Science ®Google Scholar
• D’Alincourt Carvalho-Assef AP, Leão RS, Da Silva RV, et al. Escherichia coli producing KPC-2 carbapenemase: first report in Brazil. Diagn Microbiol Infect Dis. 2010;68(3):337–338.
   PubMed Web of Science ®Google Scholar
• Del Peloso PF, Barros MFL, De Santos FA D. Serratia marcescens KPC sepsis. J Bras Patol Med Lab. 2010;46(5):365–367.
   Google Scholar
• Leão RS, Carvalho-Assef APDA, Correal JCD, et al. KPC-2 producing klebsiella pneumoniae and escherichia coli co-infection in a catheter-related infection. Clin Microbiol Infect. 2011;17(3):380–382.
   PubMed Web of Science ®Google Scholar
• Bergamasco MD, Barroso Barbosa M, De Oliveira Garcia D, et al. Infection with klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation. Traspl Infect Dis. 2012;14(2):198–205.
   PubMed Web of Science ®Google Scholar
• Almeida ACS, Cavalcanti FLS, Martins WMB, et al. First description of KPC-2-producing klebsiella oxytoca in Brazil. Antimicrob Agents Chemother. 2013;57(8):4077–4078.
   PubMed Web of Science ®Google Scholar
• Da Costa Guimarães AC, Almeida ACS, Nicoletti AG, et al. Clonal spread of carbapenem-resistant serratia marcescens isolates sharing an IncK plasmid containing blaKPC-2. Int J Antimicrob Agents. 2013;42(4):369–370.
   PubMed Web of Science ®Google Scholar
• Ribeiro VB, Andrade LN, Linhares AR, et al. Molecular characterization of klebsiella pneumoniae carbapenemase-producing isolates in southern Brazil. J Med Microbiol. 2013;62(Pt 11):1721–1727.
   PubMed Web of Science ®Google Scholar
• Freire MP, Pierrotti LC, Filho HHC, et al. Infection with klebsiella pneumoniae carbapenemase (KPC)-producing klebsiella pneumoniae in cancer patients. Eur J Clin Microbiol Infect Dis. 2015;34(2):277–286.
   PubMed Web of Science ®Google Scholar
• Arend LN, Pilonetto M, Siebra C, et al. Phenotypic and molecular characterization of 942 carbapenem-resistant enterobacteriaceae (CRE) in southern Brazil. J Infect Chemother. 2015;21(4):316–318.
   PubMed Web of Science ®Google Scholar
• Arend LN, Toledo P, Pilonetto M, et al. Molecular epidemiology of klebsiella pneumoniae carbapenemase-producing enterobacteriaceae in different facilities in Southern Brazil. Am J Infect Control. 2015;43(2):137–140.
   PubMed Web of Science ®Google Scholar
• Tuon FF, Scharf C, Rocha JL, et al. KPC-producing enterobacter aerogenes infection. Braz J Infect Dis. 2015;19(3):324–327.
   PubMed Web of Science ®Google Scholar
• Biberg CA, Rodrigues ACS, Do Carmo SF, et al. KPC-2-producing klebsiella pneumoniae in a hospital in the midwest region of Brazil. Braz J Microbiol. 2015;46(2):501–504.
   PubMed Web of Science ®Google Scholar
• Almeida ACS, De Castro KKA, Fehlberg LCC, et al. Carbapenem-resistant enterobacter gergoviae harbouring blaKPC-2 in Brazil. Int J Antimicrob Agents. 2014;44(4):369–370.
   PubMed Web of Science ®Google Scholar
• Seki LM, Pereira PS, De Souza M Da PAH, et al. Molecular epidemiology of KPC-2- producing klebsiella pneumoniae isolates in Brazil: the predominance of sequence type 437. Diagn Microbiol Infect Dis. 2011;70(2):274–277.
   PubMed Web of Science ®Google Scholar
• Andrade LN, Curiao T, Ferreira JC, et al. Dissemination of blaKPC-2 by the spread of klebsiella pneumoniae clonal complex 258 clones (ST258, ST11, ST437) and plasmids (IncFII, IncN, IncL/M) among enterobacteriaceae species in Brazil. Antimicrob Agents Chemother. 2011;55(7):3579–3583.
   PubMed Web of Science ®Google Scholar
• Pereira PS, De Araujo CFM, Seki LM, et al. Update of the molecular epidemiology of KPC-2-producing klebsiella pneumoniae in Brazil: spread of clonal complex 11 (ST11, ST437 and ST340). J Antimicrob Chemother. 2013;68(2):312–316.
   PubMed Web of Science ®Google Scholar
• Castanheira M, Costello AJ, Deshpande LM, et al. Expansion of clonal complex 258 KPC-2-producing klebsiella pneumoniae in Latin American hospitals: report of the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother. 2012;56(3):1668–1669.
   PubMed Web of Science ®Google Scholar
• Fehlberg LCC, Carvalho AMC, Campana EH, et al. Emergence of klebsiella pneumoniae-producing KPC-2 carbapenemase in Paraíba, Northeastern Brazil. Braz J Infect Dis. 2012;16(6):577–580.
   PubMed Web of Science ®Google Scholar
• Nicoletti AG, Fehlberg LCC, Picão RC, et al. Clonal complex 258, the most frequently found multilocus sequence type complex in KPC-2-producing klebsiella pneumoniae isolated in Brazilian hospitals. Antimicrob Agents Chemother. 2012;56(8):4563–4564.
   PubMed Web of Science ®Google Scholar
• Tavares CP, Pereira PS, Marques EDA, et al. Molecular epidemiology of KPC-2-producing enterobacteriaceae (non-Klebsiella pneumoniae) isolated from Brazil. Diagn Microbiol Infect Dis. 2015;82(4):326–330.
   PubMed Web of Science ®Google Scholar
• Kazmierczak KM, Biedenbach DJ, Hackel M, et al. Global dissemination of blaKPC into bacterial species beyond klebsiella pneumoniae and in vitro susceptibility to ceftazidime-avibactam and aztreonam-avibactam. Antimicrob Agents Chemother. 2016;60(8):4490–4500.
   PubMed Web of Science ®Google Scholar
• Jaskulski MR, Medeiros BC, Borges JV, et al. Assessment of extended-spectrum β-lactamase, KPC carbapenemase and porin resistance mechanisms in clinical samples of klebsiella pneumoniae and enterobacter spp. Int J Antimicrob Agents. 2013;42(1):76–79.
   PubMed Web of Science ®Google Scholar
• Cabral AB, Maciel MAV, Barros JF, et al. Detection of bla KPC-2 in proteus mirabilis in Brazil. Rev Soc Bras Med Trop. 2015;48(1):94–95.
   PubMed Web of Science ®Google Scholar
• Pasteran FG, Otaegui L, Guerriero L, et al. Klebsiella pneumoniae carbapenemase-2, Buenos Aires, Argentina. Emerg Infect Dis. 2008;14(7):1178–1180.
   PubMed Web of Science ®Google Scholar
• Gomez SA, Pasteran FG, Faccone D, et al. Clonal dissemination of klebsiella pneumoniae ST258 harbouring KPC-2 in Argentina. Clin Microbiol Infect. 2011;17(10):1520–1524.
   PubMed Web of Science ®Google Scholar
• Cejas D, Fernandez Canigia L, Nastro M, et al. Hyperendemic clone of KPC producing klebsiella pneumoniae ST 258 in Buenos Aires hospitals. Infect Genet Evol. 2012;12(3):499–501.
   PubMed Web of Science ®Google Scholar
• Córdova E, Lespada MI, Gómez N, et al. Clinical and epidemiological study of an outbreak of KPC-producing klebsiella pneumoniae infection in Buenos Aires, Argentina. Enferm Infecc Microbiol Clin. 2012;30(7):376–379.
   PubMed Web of Science ®Google Scholar
• Gregory CJ, Llata E, Stine N, et al. Outbreak of carbapenem-resistant klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant. Infect Control Hosp Epidemiol. 2010;31(5):476–484.
   PubMed Web of Science ®Google Scholar
• Robledo IE, Aquino EE, Vázquez GJ. Detection of the KPC gene in escherichia coli, klebsiella pneumoniae, pseudomonas aeruginosa, and acinetobacter baumannii during a PCR-based nosocomial surveillance study in Puerto Rico. Antimicrob Agents Chemother. 2011;55(6):2968–2970.
   PubMed Web of Science ®Google Scholar
• Marcano D, De Jesús A, Hernández L, et al. Frequency of enzymes associated with reduced sensitivity to beta-lactam antibiotics in enterobacteria isolates, Caracas, Venezuela. Rev Panam Salud Publica. 2011;30(6):529–534.
   PubMed Web of Science ®Google Scholar
• Luque J, Bohórquez P, Marcano D, et al. Spread of carbapenemase-producing enterobacteriaceae type KPC in Venezuela. Bol Venez Infectol. 2012;23(1):13–19.
   Google Scholar
• Pena MC, Vierma H, Farina E, et al. First detection of escherichia coli KPC carbapenemase in Venezuela. 51st ICAAC. Chicago, USA: ASM; 2011. p. Abstract C1–1219.
   Google Scholar
• Labrador I, Araque M. First description of KPC-2-producing klebsiella oxytoca isolated from a pediatric patient with nosocomial pneumonia in Venezuela. Case Rep Infect Dis. 2014;434987:2014.
   Google Scholar
• Rodríguez-Zulueta P, Silva-Sánchez J, Barrios H, et al. First outbreak of KPC-3-producing klebsiella pneumoniae (ST258) clinical isolates in a Mexican medical center. Antimicrob Agents Chemother. 2013;57(8):4086–4088.
   PubMed Web of Science ®Google Scholar
• Garza-Ramos U, Moreno-Dominguez S, Hernández-Castro R, et al. Identification and characterization of imipenem-resistant klebsiella pneumoniae and susceptible klebsiella variicola isolates obtained from the same patient. Microb Drug Resist. 2016;22(3):179–184.
   PubMed Web of Science ®Google Scholar
• Garza-Ramos U, Barrios H, Reyna-Flores F, et al. Characteristics of KPC-2-producing klebsiella pneumoniae (ST258) clinical isolates from outbreaks in 2 Mexican medical centers. Diagn Microbiol Infect Dis. 2014;79(4):483–485.
   PubMed Web of Science ®Google Scholar
• Iñiguez D, Zurita J, Alcocer I, et al. Klebsiella pneumoniae carbapenemase type 2-producing bacteria: first case report in Ecuador. Rev Fac Cien Med. 2012;37:39–42.
   Google Scholar
• Zurita J, Alcocer I, Ortega-Paredes D, et al. Carbapenem-hydrolysing β-lactamase KPC-2 in klebsiella pneumoniae isolated in ecuadorian hospitals. J Glob Antimicrob Resist. 2013;1(4):229–230.
   PubMed Web of Science ®Google Scholar
• Cifuentes M, García P, San Martín P, et al. First isolation of KPC in Chile: from Italy to a public hospital in Santiago. Rev Chil Infectol. 2012;29(2):224–228.
   PubMed Web of Science ®Google Scholar
• Marquez C, Ingold A, Echeverría N, et al. Emergence of KPC-producing klebsiella pneumoniae in Uruguay: infection control and molecular characterization. New Microbes New Infect. 2014;2(3):58–63.
   PubMedGoogle Scholar
• Quiñones D, Hart M, Espinosa F, et al. Emergence of klebsiella pneumoniae clinical isolates producing KPC-2 carbapenemase in Cuba. New Microbes New Infect. 2014;2(4):123–126.
   PubMedGoogle Scholar
• Instituto de Salud Pública de Chile. [Surveillance of antimicrobial resistance in bacteria that can cause healthcare-associated infections]. Bol Inst Salud Pública Chile. 2015;5(4):1–25.
   Google Scholar
• Barría-Loaiza C, Pincheira A, Quezada M, et al. Molecular typing and genetic environment of the blaKPC gene in Chilean isolates of klebsiella pneumoniae. J Glob Antimicrob Resist. 2016;4:28–34.
   PubMed Web of Science ®Google Scholar
• Zúñiga J, Cruz G, Pérez C, et al. The combined-disk boronic acid test as an accurate strategy for the detection of KPC carbapenemase in Central America. J Infect Dev Ctries. 2016;10(3):298–303.
   PubMed Web of Science ®Google Scholar
• Jones RN, Guzman-Blanco M, Gales AC, et al. Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011). Braz J Infect Dis. 2013;17(6):672–681.
   PubMed Web of Science ®Google Scholar
• Velásquez J, Hernández R, Pamo O, et al. Carbapenem-resistant klebsiella pneumoniae: first case of KPC type carbapenemase in Peru. Rev Soc Peru Med Interna. 2013;26(4):192–196.
   Google Scholar
• Miriagou V, Tzouvelekis LS, Rossiter S, et al. Imipenem resistance in a salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob Agents Chemother. 2003;47(4):1297–1300.
   PubMed Web of Science ®Google Scholar
• Rodríguez E, Bautista A, Barrero L. First report of a salmonella enterica serovar typhimurium isolate with carbapenemase (KPC-2) in Colombia. Antimicrob Agents Chemother. 2014;58(2):1263–1264.
   PubMed Web of Science ®Google Scholar
• Jure MA, Duprilot M, Musa HE, et al. Emergence of KPC-2-producing salmonella enterica serotype schwarzengrund in Argentina. Antimicrob Agents Chemother. 2014;58(10):6335–6336.
   PubMed Web of Science ®Google Scholar
• Melgarejo TN, Álvarez M, Irala J, et al. Primer aislamiento de Salmonella productora de KPC en Paraguay. 10° Congreso Paraguayo de Infectología. Asunción, Paraguay: Sociedad Paraguaya de Infectología; 2015.
   Google Scholar
• Ribeiro VB, Zavascki AP, Nodari CS, et al. Detection of blaKPC-2 in a carbapenem-resistant kluyvera georgiana. J Antimicrob Chemother. 2012;67(11):2776–2777.
   PubMed Web of Science ®Google Scholar
• Wolter DJ, Khalaf N, Robledo IE, et al. Surveillance of carbapenem-resistant pseudomonas aeruginosa isolates from Puerto Rican medical center hospitals: dissemination of KPC and IMP-18 β-lactamases. Antimicrob Agents Chemother. 2009;53(4):1660–1664.
   PubMed Web of Science ®Google Scholar
• Wolter DJ, Kurpiel PM, Woodford N, et al. Phenotypic and enzymatic comparative analysis of the novel KPC variant KPC-5 and its evolutionary variants, KPC-2 and KPC-4. Antimicrob Agents Chemother. 2009;53(2):557–562.
   PubMed Web of Science ®Google Scholar
• Akpaka PE, Swanston WH, Ihemere HN, et al. Emergence of KPC-producing pseudomonas aeruginosa in trinidad and tobago. J Clin Microbiol. 2009;47(8):2670–2671.
   PubMed Web of Science ®Google Scholar
• Almeida ACS, Vilela MA, Cavalcanti FLS, et al. First description of KPC-2-producing pseudomonas putida in Brazil. Antimicrob Agents Chemother. 2012;56(4):2205–2206.
   PubMed Web of Science ®Google Scholar
• Jácome PRL De A, Alves LR, Cabral AB, et al. First report of KPC-producing pseudomonas aeruginosa in Brazil. Antimicrob Agents Chemother. 2012;56(9):4990.
   PubMed Web of Science ®Google Scholar
• Rizek C, Fu L, Dos Santos LC, et al. Characterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistance. Ann Clin Microbiol Antimicrob. 2014;13(1):43.
   PubMed Web of Science ®Google Scholar
• Pasteran F, Faccone D, Gomez S, et al. Detection of an international multiresistant clone belonging to sequence type 654 involved in the dissemination of KPC-producing pseudomonas aeruginosa in Argentina. J Antimicrob Chemother. 2012;67(5):1291–1293.
   PubMed Web of Science ®Google Scholar
• Santella G, Cittadini R, Papalia M, et al. First clonal spread of KPC-producing pseudomonas aeruginosa in Buenos Aires, Argentina. Infect Genet Evol. 2012;12(8):2003–2005.
   PubMed Web of Science ®Google Scholar
• García Ramírez D, Nicola F, Zarate S, et al. Emergence of pseudomonas aeruginosa with KPC-type carbapenemase in a teaching hospital: an 8-year study. J Med Microbiol. 2013;62(Pt 10):1565–1570.
   PubMed Web of Science ®Google Scholar
• Robledo IE, Aquino EE, Santé MI, et al. Detection of KPC in acinetobacter spp. in Puerto Rico. Antimicrob Agents Chemother. 2010;54(3):1354–1357.
   PubMed Web of Science ®Google Scholar
• Poirel L, Le Thomas I, Naas T, et al. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum β-lactamase, and the class 1 integron In52 from klebsiella pneumoniae. Antimicrob Agents Chemother. 2000;44(3):622–632.
   PubMed Web of Science ®Google Scholar
• Poirel L, Weldhagen GF, Naas T, et al. GES-2, a class A β-lactamase from pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob Agents Chemother. 2001;45(9):2598–2603.
   PubMed Web of Science ®Google Scholar
• Wachino J, Doi Y, Yamane K, et al. Molecular characterization of a cephamycin-hydrolyzing and inhibitor-resistant class A β-lactamase, GES-4, possessing a single G170S substitution in the Ω-loop. Antimicrob Agents Chemother. 2004;48(8):2905–2910.
   PubMed Web of Science ®Google Scholar
• Vourli S, Giakkoupi P, Miriagou V, et al. Novel GES/IBC extended-spectrum β-lactamase variants with carbapenemase activity in clinical enterobacteria. FEMS Microbiol Lett. 2004;234(2):209–213.
   PubMed Web of Science ®Google Scholar
• Moubareck C, Brémont S, Conroy M-C, et al. GES-11, a novel integron-associated GES variant in acinetobacter baumannii. Antimicrob Agents Chemother. 2009;53(8):3579–3581.
   PubMed Web of Science ®Google Scholar
• Bonnin RA, Nordmann P, Potron A, et al. GES-type extended-spectrum β-lactamase in acinetobacter baumannii. Antimicrob Agents Chemother. 2011;55(1):349–354.
   PubMed Web of Science ®Google Scholar
• Barbosa PP. Genetic and biochemical characterization of GES-16, a novel GES-type β-lactamase with carbapenemase activity in Serratia marcescens [master’s thesis]. São Paulo, Brazil: Universidade Federal de São Paulo; 2011.
   Google Scholar
• Bebrone C, Bogaerts P, Delbrück H, et al. GES-18, a new carbapenem-hydrolyzing GES-type β-lactamase from pseudomonas aeruginosa that contains Ile80 and Ser170 residues. Antimicrob Agents Chemother. 2013;57(1):396–401.
   PubMed Web of Science ®Google Scholar
• Barrios H, Garza-Ramos U, Ochoa-Sanchez LE, et al. A plasmid-encoded class 1 integron contains GES-type extended-spectrum β-lactamases in enterobacteriaceae clinical isolates in Mexico. Antimicrob Agents Chemother. 2012;56(7):4032–4034.
   PubMed Web of Science ®Google Scholar
• Pasteran F, Faccone D, Campos K, et al. Dissemination of GES extended-spectrum β-lactamase-producing Pseudomonas aeruginosa (PA) in Argentina. 44th ICAAC, Washington, DC, USA:American Society for Microbiology p. Abstract C2–1327. 2004.
   Google Scholar
• Da Fonseca EL, Vieira VV, Cipriano R, et al. Emergence of blaGES-5 in clinical colistin-only-sensitive (COS) pseudomonas aeruginosa strain in Brazil. J Antimicrob Chemother. 2007;59(3):576–577.
   PubMed Web of Science ®Google Scholar
• Picão RC, Poirel L, Gales AC, et al. Diversity of β-lactamases produced by ceftazidime-resistant pseudomonas aeruginosa isolates causing bloodstream infections in Brazil. Antimicrob Agents Chemother. 2009;53(9):3908–3913.
   PubMed Web of Science ®Google Scholar
• Polotto M, Casella T, De Lucca Oliveira MG, et al. Detection of P. aeruginosa harboring blaCTX-M-2, blaGES-1 and blaGES-5, blaIMP-1 and blaSPM-1 causing infections in Brazilian tertiary-care hospital. BMC Infect Dis. 2012;12:176.
   PubMed Web of Science ®Google Scholar
• Picão RC, Santos AF, Nicoletti AG, et al. Detection of GES-5-producing klebsiella pneumoniae in Brazil. J Antimicrob Chemother. 2010;65(4):796–797.
   PubMed Web of Science ®Google Scholar
• Ribeiro VB, Falci DR, Rozales FP, et al. Carbapenem-resistant GES-5-producing klebsiella pneumoniae in southern Brazil. Braz J Infect Dis. 2014;18(2):231–232.
   PubMed Web of Science ®Google Scholar
• Castillo-Vera J, Ribas-Aparicio RM, Nicolau CJ, et al. Unusual diversity of acquired β-lactamases in multidrug-resistant pseudomonas aeruginosa isolates in a Mexican hospital. Microb Drug Resist. 2012;18(5):471–478.
   PubMed Web of Science ®Google Scholar
• Garza-Ramos U, Barrios H, Reyna-Flores F, et al. Widespread of ESBL- and carbapenemase GES-type genes on carbapenem-resistant pseudomonas aeruginosa clinical isolates: a multicenter study in Mexican hospitals. Diagn Microbiol Infect Dis. 2015;81(2):135–137.
   PubMed Web of Science ®Google Scholar
• Nicoletti AG, Marcondes MFM, Martins WMBS, et al. Characterization of BKC-1 class A carbapenemase from klebsiella pneumoniae clinical isolates in Brazil. Antimicrob Agents Chemother. 2015;59(9):5159–5164.
   PubMed Web of Science ®Google Scholar
• Martins WMBS, Nicoletti AG, Santos SR, et al. Frequency of BKC-1-producing klebsiella species isolates. Antimicrob Agents Chemother. 2016;60(8):5044–5046.
   PubMed Web of Science ®Google Scholar
• Queenan AM, Carbapenemases: BK. the versatile β-lactamases. Clin Microbiol Rev. 2007;20(3):440–458.
   PubMed Web of Science ®Google Scholar
• Watanabe M, Iyobe S, Inoue M, et al. Transferable imipenem resistance in pseudomonas aeruginosa. Antimicrob Agents Chemother. 1991;35(1):147–151.
   PubMed Web of Science ®Google Scholar
• Osano E, Arakawa Y, Wacharotayankun R, et al. Molecular characterization of an enterobacterial metallo β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother. 1994;38(1):71–78.
   PubMed Web of Science ®Google Scholar
• Ito H, Arakawa Y, Ohsuka S, et al. Plasmid-mediated dissemination of the metallo-β-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens. Antimicrob Agents Chemother. 1995;39(4):824–829.
   PubMed Web of Science ®Google Scholar
• Arakawa Y, Murakami M, Suzuki K, et al. A novel integron-like element carrying the metallo-β-lactamase gene blaIMP. Antimicrob Agents Chemother. 1995;39(7):1612–1615.
   PubMed Web of Science ®Google Scholar
• Zhao W-H, Hu Z-Q. IMP-type metallo-β-lactamases in gram-negative bacilli: distribution, phylogeny, and association with integrons. Crit Rev Microbiol. 2011;37(3):214–226.
   PubMed Web of Science ®Google Scholar
• Gales AC, Tognim MCB, Reis AO, et al. Emergence of an IMP-like metallo-enzyme in an acinetobacter baumannii clinical strain from a Brazilian teaching hospital. Diagn Microbiol Infect Dis. 2003;45(1):77–79.
   PubMed Web of Science ®Google Scholar
• Lincopan N, McCulloch JA, Reinert C, et al. First isolation of metallo-β-lactamase-producing multiresistant klebsiella pneumoniae from a patient in Brazil. J Clin Microbiol. 2005;43(1):516–519.
   PubMed Web of Science ®Google Scholar
• Sader HS, Reis AO, Silbert S, et al. IMPs, VIMs and SPMs: the diversity of metallo-β-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in a Brazilian hospital. Clin Microbiol Infect. 2005;11(1):73–76.
   PubMed Web of Science ®Google Scholar
• Marra AR, Pereira CAP, Gales AC, et al. Bloodstream infections with metallo-β-lactamase-producing pseudomonas aeruginosa: epidemiology, microbiology, and clinical outcomes. Antimicrob Agents Chemother. 2006;50(1):388–390.
   PubMed Web of Science ®Google Scholar
• Martins AF, Zavascki AP, Gaspareto PB, et al. Dissemination of pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-β-lactamases in hospitals from southern Brazil. Infection. 2007;35(6):457–460.
   PubMed Web of Science ®Google Scholar
• Gaspareto PB, Martins AF, Zavascki AP, et al. Occurrence of blaSPM-1 and blaIMP-1 genes of metallo-β-lactamases in clinical isolates of pseudomonas aeruginosa from three universitary hospitals in the city of Porto Alegre, Brazil. Braz J Microbiol. 2007;38:108–109.
   Web of Science ®Google Scholar
• Silva FM, Carmo MS, Silbert S, et al. SPM-1-producing pseudomonas aeruginosa: analysis of the ancestor relationship using multilocus sequence typing, pulsed-field gel electrophoresis, and automated ribotyping. Microb Drug Resist. 2011;17(2):215–220.
   PubMed Web of Science ®Google Scholar
• Camargo CH, Bruder-Nascimento A, Mondelli AL, et al. Detection of SPM and IMP metallo-β-lactamases in clinical specimens of pseudomonas aeruginosa from a Brazilian public tertiary hospital. Braz J Infect Dis. 2011;15(5):478–481.
   PubMed Web of Science ®Google Scholar
• Fehlberg LCC, Xavier DE, Peraro PP, et al. Beta-lactam resistance mechanisms in pseudomonas aeruginosa strains causing bloodstream infections: comparative results between Brazilian and American isolates. Microb Drug Resist. 2012;18(4):402–407.
   PubMed Web of Science ®Google Scholar
• Lucena A, Dalla Costa LM, Nogueira KS, et al. Nosocomial infections with metallo-beta-lactamase-producing pseudomonas aeruginosa: molecular epidemiology, risk factors, clinical features and outcomes. J Hosp Infect. 2014;87(4):234–240.
   PubMed Web of Science ®Google Scholar
• Sader HS, Castanheira M, Mendes RE, et al. Dissemination and diversity of metallo-β-lactamases in Latin America: report from the SENTRY antimicrobial surveillance program. Int J Antimicrob Agents. 2005;25(1):57–61.
   PubMed Web of Science ®Google Scholar
• Tognim MCB, Gales AC, Penteado AP, et al. Dissemination of IMP-1 metallo-β-lactamase-producing acinetobacter species in a Brazilian teaching hospital. Infect Control Hosp Epidemiol. 2006;27(7):742–747.
   PubMed Web of Science ®Google Scholar
• Mendes RE, Castanheira M, Toleman MA, et al. Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6ʹ)-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital. Antimicrob Agents Chemother. 2007;51(7):2611–2614.
   PubMed Web of Science ®Google Scholar
• Picão RC, Andrade SS, Nicoletti AG, et al. Metallo-β-lactamase detection: comparative evaluation of double-disk synergy versus combined disk tests for IMP-, GIM-, SIM-, SPM-, or VIM-producing isolates. J Clin Microbiol. 2028–37;46(6):2008.
   Google Scholar
• Mostachio AK, Levin AS, Rizek C, et al. High prevalence of OXA-143 and alteration of outer membrane proteins in carbapenem-resistant acinetobacter spp. isolates in Brazil. Int J Antimicrob Agents. 2012;39(5):396–401.
   PubMed Web of Science ®Google Scholar
• Lincopan N, Leis R, Vianello MA, et al. Enterobacteria producing extended-spectrum β-lactamases and IMP-1 metallo-β-lactamases isolated from Brazilian hospitals. J Med Microbiol. 2006;55(Pt 11):1611–1613.
   PubMed Web of Science ®Google Scholar
• Penteado AP, Castanheira M, Pignatari ACC, et al. Dissemination of blaIMP-1-carrying integron In86 among klebsiella pneumoniae isolates harboring a new trimethoprim resistance gene dfr23. Diagn Microbiol Infect Dis. 2009;63(1):87–91.
   PubMed Web of Science ®Google Scholar
• Mendes RE, Toleman MA, Ribeiro J, et al. Integron carrying a novel metallo-β-lactamase gene, blaIMP-16, and a fused form of aminoglycoside-resistant gene aac(6ʹ)-30/aac(6ʹ)-Ib’: report from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother. 2004;48(12):4693–4702.
   PubMed Web of Science ®Google Scholar
• Cayô R, Rodrigues-Costa F, Matos AP, et al. Identification of a new integron harboring blaIMP-10 in carbapenem-resistant acinetobacter baumannii clinical isolates. Antimicrob Agents Chemother. 2015;59(6):3687–3689.
   PubMed Web of Science ®Google Scholar
• Silva KE, Cayô R, Carvalhaes CG, et al. Coproduction of KPC-2 and IMP-10 in carbapenem-resistant Serratia marcescens isolates from an outbreak in a Brazilian teaching hospital. J Clin Microbiol. 2015;53(7):2324–2328.
   PubMed Web of Science ®Google Scholar
• Kazmierczak KM, Rabine S, Hackel M, et al. Multiyear, multinational survey of the incidence and global distribution of metallo-β-lactamase-producing enterobacteriaceae and pseudomonas aeruginosa. Antimicrob Agents Chemother. 2016;60(2):1067–1078.
   PubMed Web of Science ®Google Scholar
• Garza-Ramos U, Tinoco P, Silva-Sanchez J, et al. Metallo-β-lactamase IMP-18 is located in a class 1 integron (In96) in a clinical isolate of pseudomonas aeruginosa from Mexico. Int J Antimicrob Agents. 2008;31(1):78–80.
   PubMed Web of Science ®Google Scholar
• Sánchez-Martinez G, Garza-Ramos UJ, Reyna-Flores FL, et al. In169, a new class 1 integron that encoded blaIMP-18 in a multidrug-resistant pseudomonas aeruginosa isolate from Mexico. Arch Med Res. 2010;41(4):235–239.
   PubMed Web of Science ®Google Scholar
• Garza-Ramos U, Morfin-Otero R, Sader HS, et al. Metallo-β-lactamase gene blaIMP-15 in a class 1 integron, In95, from pseudomonas aeruginosa clinical isolates from a hospital in Mexico. Antimicrob Agents Chemother. 2008;52(8):2943–2946.
   PubMed Web of Science ®Google Scholar
• Quinones-Falconi F, Galicia-Velasco M, Marchiaro P, et al. Emergence of pseudomonas aeruginosa strains producing metallo-β-lactamases of the IMP-15 and VIM-2 types in Mexico. Clin Microbiol Infect. 2010;16(2):126–131.
   PubMed Web of Science ®Google Scholar
• Garza-Ramos JU, Sanchez-Martinez G, Barajas JM, et al. Variability of the blaIMP-15-containing integrons, highly related to In95, on an endemic clone of pseudomonas aeruginosa in Mexico. Microb Drug Resist. 2010;16(3):191–195.
   PubMed Web of Science ®Google Scholar
• González-Chávez MI, Morfin-Otero R, Jarillo-Quijada C, et al. First report of blaVIM-4, blaIMP-1 and blaOXA-24-producing Acinetobacter baumannii clones isolated from nosocomial infections in Mexico. 51st ICAAC. Chicago, USA: American Society for Microbiology. 2011. p. Abstract C2–648.
   Google Scholar
• Gales AC, Castanheira M, Jones RN, et al. Antimicrobial resistance among gram-negative bacilli isolated from Latin America: results from SENTRY antimicrobial surveillance program (Latin America, 2008-2010). Diagn Microbiol Infect Dis. 2012;73(4):354–360.
   PubMed Web of Science ®Google Scholar
• Fritsche TR, Sader HS, Toleman MA, et al. Emerging metallo-β-lactamase-mediated resistances: a summary report from the worldwide SENTRY antimicrobial surveillance program. Clin Infect Dis. 2005;41(Suppl 4):S276–8.
   PubMed Web of Science ®Google Scholar
• Fiorilli G, Faccone D, Lopardo H, et al. Emergence of metallo-β-lactamases in acinetobacter spp clinical isolates from Argentina. Rev Esp Quimioter. 2010;23(2):100–102.
   PubMed Web of Science ®Google Scholar
• Cejas D, Almuzara M, Santella G, et al. Phenotypic and genotypic characterization of imipenem-resistant pseudomonas aeruginosa isolated in a Buenos Aires hospital. Rev Argent Microbiol. 2008;40(4):238–245.
   PubMed Web of Science ®Google Scholar
• Santella G, Cuirolo A, Almuzara M, et al. Full resistance and decreased susceptibility to carbapenems in IMP-13-producing pseudomonas aeruginosa isolates from an outbreak. Antimicrob Agents Chemother. 2010;54(3):1381–1382.
   PubMed Web of Science ®Google Scholar
• Santella G, Pollini S, Docquier J-D, et al. Intercontinental dissemination of IMP-13-producing pseudomonas aeruginosa belonging in sequence type 621. J Clin Microbiol. 2010;48(11):4342–4343.
   PubMed Web of Science ®Google Scholar
• Gomez S, Rapoport M, Togneri A, et al. Emergence of metallo-β-lactamases in enterobacteriaceae from Argentina. Diagn Microbiol Infect Dis. 2011;69(1):94–97.
   PubMed Web of Science ®Google Scholar
• Togneri AM, Gómez SA, Podestá LB, et al. Dissemination of blaIMP-8 among enterobacteriaceae isolates from a Buenos Aires hospital. Rev Argent Microbiol. 2013;45(2):104–109.
   PubMed Web of Science ®Google Scholar
• Toval F, Guzmán-Marte A, Madriz V, et al. Predominance of carbapenem-resistant pseudomonas aeruginosa isolates carrying blaIMP and blaVIM metallo-β-lactamases in a major hospital in Costa Rica. J Med Microbiol. 2015;64(Pt 1):37–43.
   PubMed Web of Science ®Google Scholar
• Martínez T, Vazquez GJ, Aquino EE, et al. Two novel class I integron arrays containing IMP-18 metallo-β-lactamase gene in Pseudomonas aeruginosa clinical isolates from puerto rico. Antimicrob Agents Chemother. 2012;56(4):2119–2121.
   PubMed Web of Science ®Google Scholar
• Martínez T, Vázquez GJ, Aquino EE, et al. First report of a pseudomonas aeruginosa clinical isolate co-harbouring KPC-2 and IMP-18 carbapenemases. Int J Antimicrob Agents. 2012;39(6):542–543.
   PubMed Web of Science ®Google Scholar
• Gonzales-Escalante E, Vicente-Taboada W, Champi-Merino R, et al. Metallo-β-lactamases in clinical isolates of pseudomonas aeruginosa in Lima, Peru. Rev Peru Med Exp Salud Publica. 2013;30(2):241–245.
   PubMedGoogle Scholar
• Perozo Mena AJ, Castellano González MJ, Chávez Kathyuska T, et al. Assessment of phenotypic methods for metallobetalactamase detection in clinical isolates of pseudomonas aeruginosa. Kasmera. 2013;41(2):115–126.
   Google Scholar
• Instituto Nacional de Salud. Caracterización fenotípica y genotípica de perfiles de resistencia antimicrobiana de aislamientos bacterianos recuperados en infecciones asociadas a la atención en salud (IAAS) septiembre 2012 - junio 2014. Colombia. Bogota DC, Colombia:Instituto Nacional de Salud. 2014.
   Google Scholar
• Zhao W, Hu Z. Epidemiology and genetics of VIM-type metallo-β-lactamases in gram-negative bacilli. Future Microbiol. 2011;6(3):317–333.
   PubMed Web of Science ®Google Scholar
• Lauretti L, Riccio ML, Mazzariol A, et al. Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother. 1999;43(7):1584–1590.
   PubMed Web of Science ®Google Scholar
• Cornaglia G, Mazzariol A, Lauretti L, et al. Hospital outbreak of carbapenem-resistant pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-β-lactamase. Clin Infect Dis. 2000;31(5):1119–1125.
   PubMed Web of Science ®Google Scholar
• Poirel L, Naas T, Nicolas D, et al. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother. 2000;44(4):891–897.
   PubMed Web of Science ®Google Scholar
• Mendes RE, Castanheira M, Garcia P, et al. First isolation of blaVIM-2 in Latin America: report from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother. 2004;48(4):1433–1434.
   PubMed Web of Science ®Google Scholar
• Pérez IA, García CP, Poggi MH, et al. Presence of metallo β-lactamases in imipenem-resistant pseudomonas aeruginosa. Rev Med Chile. 2008;136:423–432.
   PubMed Web of Science ®Google Scholar
• Sánchez GDI, Marcano ZD, Spadola CE, et al. VIM-type metalloenzymes detected in clinical isolates of pseudomonas aeruginosa in four venezuelan hospitals. Rev Del Inst Nac Hig Rafael Rangel. 2008;39(2):17–22.
   Google Scholar
• Guevara A, De Waard J, Araque M. blaVIM-2 gene detection in metallo-β-lactamase-producing pseudomonas aeruginosa strains isolated in an intensive care unit in Ciudad Bolívar, Venezuela. Rev Chil Infectol. 2009;26(4):336–341.
   PubMed Web of Science ®Google Scholar
• Guevara A, Sierra RCI, De Waard J. Molecular characterization of carbapenem-resistant pseudomonas aeruginosa from four hospitals of Venezuela. Rev Chil Infectol. 2012;29(6):614–621.
   PubMed Web of Science ®Google Scholar
• Guevara A, Sahai JM, Tedesco-Maiullari R. Clonal persistence of pseudomonas aeruginosa producing metallo-β-lactamases in a hospital in Ciudad Bolivar, Venezuela. Rev Soc Venez Microbiol. 2015;35:77–82.
   Google Scholar
• Franco MRG, Caiaffa-Filho HH, Burattini MN, et al. Metallo-β-lactamases among imipenem-resistant pseudomonas aeruginosa in a Brazilian university hospital. Clinics. 2010;65(9):825–829.
   PubMed Web of Science ®Google Scholar
• Paez J, Levin AS, Fu L, et al. Clusters of infection due to metallo-β-lactamase-producing pseudomonas aeruginosa in stem cell transplant and haematology units. J Hosp Infect. 2011;77(1):76–77.
   PubMed Web of Science ®Google Scholar
• Crespo MP, Woodford N, Sinclair A, et al. Outbreak of carbapenem-resistant pseudomonas aeruginosa producing VIM-8, a novel metallo-β-lactamase, in a tertiary care center in Cali, Colombia. J Clin Microbiol. 2004;42(11):5094–5101.
   PubMed Web of Science ®Google Scholar
• Villegas MV, Lolans K, Del Rosario Olivera M, et al. First detection of metallo-β-lactamase VIM-2 in pseudomonas aeruginosa isolates from Colombia. Antimicrob Agents Chemother. 2006;50(1):226–229.
   PubMed Web of Science ®Google Scholar
• Correa A, Montealegre MC, Mojica MF, et al. First report of a pseudomonas aeruginosa isolate coharboring KPC and VIM carbapenemases. Antimicrob Agents Chemother. 2012;56(10):5422–5423.
   PubMed Web of Science ®Google Scholar
• Vanegas JM, Cienfuegos AV, Ocampo AM, et al. Similar frequencies of pseudomonas aeruginosa isolates producing KPC and VIM carbapenemases in diverse genetic clones at tertiary-care hospitals in Medellín, Colombia. J Clin Microbiol. 2014;52(11):3978–3986.
   PubMed Web of Science ®Google Scholar
• Correa A, Del Campo R, Perenguez M, et al. Dissemination of high-risk clones of extensively drug-resistant pseudomonas aeruginosa in colombia. Antimicrob Agents Chemother. 2015;59(4):2421–2425.
   PubMed Web of Science ®Google Scholar
• Pasteran F, Faccone D, Petroni A, et al. Novel variant (blaVIM-11) of the metallo-β-lactamase blaVIM family in a GES-1 extended-spectrum-β-lactamase-producing pseudomonas aeruginosa clinical isolate in Argentina. Antimicrob Agents Chemother. 2005;49(1):474–475.
   PubMed Web of Science ®Google Scholar
• Marchiaro P, Tomatis PE, Mussi MA, et al. Biochemical characterization of metallo-β-lactamase VIM-11 from a pseudomonas aeruginosa clinical strain. Antimicrob Agents Chemother. 2008;52(6):2250–2252.
   PubMed Web of Science ®Google Scholar
• Pagniez G, Radice M, Cuirolo A, et al. Prevalence of metallo-β-lactamase in carbapenem resistant pseudomonas aeruginosa at a university hospital of Buenos Aires city. Rev Argent Microbiol. 2006;38(1):33–37.
   PubMedGoogle Scholar
• Almuzara M, Radice M, De Gárate N, et al. VIM-2-producing pseudomonas putida, Buenos Aires. Emerg Infect Dis. 2007;13(4):668–669.
   PubMed Web of Science ®Google Scholar
• Marchiaro P, Viale AM, Ballerini V, et al. First report of a Tn402-like class 1 integron carrying blaVIM-2 in pseudomonas putida from Argentina. J Infect Dev Ctries. 2010;4(6):412–416.
   PubMed Web of Science ®Google Scholar
• Almuzara MN, Vazquez M, Tanaka N, et al. First case of human infection due to pseudomonas fulva, an environmental bacterium isolated from cerebrospinal fluid. J Clin Microbiol. 2010;48(2):660–664.
   PubMed Web of Science ®Google Scholar
• Ingold AJ, Castro M, Nabón A, et al. metallo-ß-lactamase gene detection in a class 1 integron associated to blaCTX-M-2 in a pseudomonas aeruginosa clinical isolate in Uruguay: first communication. Rev Argent Microbiol. 2011;43(3):198–202.
   PubMed Web of Science ®Google Scholar
• Marcano D, Pasterán F, Rapoport M, et al. First isolation of a VIM-producing klebsiella pneumoniae from a seven-year-old child in Venezuela. J Infect Dev Ctries. 2008;2(3):241–244.
   PubMed Web of Science ®Google Scholar
• Martínez D, Rodulfo HE, Rodríguez L, et al. First report of metallo-β-lactamases producing enterobacter spp. strains from Venezuela. Rev Inst Med Trop Sao Paulo. 2014;56(1):67–69.
   PubMed Web of Science ®Google Scholar
• Martínez D, Marcano D, Rodulfo H, et al. KPC and VIM producing enterobacter cloacae strain from a hospital in northeastern Venezuela. Invest Clin. 2015;56(2):182–187.
   PubMed Web of Science ®Google Scholar
• Morfin-Otero R, Rodriguez-Noriega E, Deshpande LM, et al. Dissemination of a blaVIM-2-carrying integron among enterobacteriaceae species in Mexico: report from the SENTRY antimicrobial surveillance program. Microb Drug Resist. 2009;15(1):33–35.
   PubMed Web of Science ®Google Scholar
• Montealegre MC, Correa A, Briceño DF, et al. Novel VIM metallo-β-lactamase variant, VIM-24, from a klebsiella pneumoniae isolate from Colombia. Antimicrob Agents Chemother. 2011;55(5):2428–2430.
   PubMed Web of Science ®Google Scholar
• Rojas LJ, Mojica MF, Blanco VM, et al. Emergence of klebsiella pneumoniae coharboring KPC and VIM carbapenemases in Colombia. Antimicrob Agents Chemother. 2013;57(2):1101–1102.
   PubMed Web of Science ®Google Scholar
• Nastro M, Monge R, Zintgraff J, et al. First nosocomial outbreak of VIM-16-producing serratia marcescens in Argentina. Clin Microbiol Infect. 2013;19(7):617–619.
   PubMed Web of Science ®Google Scholar
• Almuzara MN, Barberis CM, Rodríguez CH, et al. First report of an extensively drug-resistant VIM-2 metallo-β-lactamase-producing brevundimonas diminuta clinical isolate. J Clin Microbiol. 2012;50(8):2830–2832.
   PubMed Web of Science ®Google Scholar
• Alcántar-Curiel MD, García-Torres LF, González-Chávez MI, et al. Molecular mechanisms associated with nosocomial carbapenem-resistant acinetobacter baumannii in Mexico. Arch Med Res. 2014;45(7):553–560.
   PubMed Web of Science ®Google Scholar
• Cornaglia G, Giamarellou H, Rossolini GM. Metallo-β-lactamases: a last frontier for β-lactams? Lancet Infect Dis. 2011;11(5):381–393.
   PubMed Web of Science ®Google Scholar
• Shahcheraghi F, Abbasalipour M, Feizabadi MM, et al. Isolation and genetic characterization of metallo-β-lactamase and carbapenamase producing strains of acinetobacter baumannii from patients at Tehran hospitals. Iran J Microbiol. 2011;3(2):68–74.
   PubMedGoogle Scholar
• Toleman MA, Simm AM, Murphy TA, et al. Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme. J Antimicrob Chemother. 2002;50(5):673–679.
   PubMed Web of Science ®Google Scholar
• Poirel L, Magalhaes M, Lopes M, et al. Molecular analysis of metallo-β-lactamase gene blaSPM-1-surrounding sequences from disseminated pseudomonas aeruginosa isolates in Recife, Brazil. Antimicrob Agents Chemother. 2004;48(4):1406–1409.
   PubMed Web of Science ®Google Scholar
• Salabi AE, Toleman MA, Weeks J, et al. First report of the metallo-β-lactamase SPM-1 in Europe. Antimicrob Agents Chemother. 2010;54(1):582.
   PubMed Web of Science ®Google Scholar
• Toleman MA, Bennett PM, Walsh TR. ISCR elements: novel gene-capturing systems of the 21st century? Microbiol Mol Biol Rev. 2006;70(2):296–316.
   PubMed Web of Science ®Google Scholar
• Fonseca EL, Marin MA, Encinas F, et al. Full characterization of the integrative and conjugative element carrying the metallo-β-lactamase blaSPM-1 and bicyclomycin bcr1 resistance genes found in the pandemic pseudomonas aeruginosa clone SP/ST277. J Antimicrob Chemother. 2015;70(9):2547–2550.
   PubMed Web of Science ®Google Scholar
• Hopkins KL, Meunier D, Findlay J, et al. SPM-1 metallo-β-lactamase-producing pseudomonas aeruginosa ST277 in the UK. J Med Microbiol. 2016;65(7):696–697.
   PubMed Web of Science ®Google Scholar
• Gales AC, Menezes LC, Silbert S, et al. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant pseudomonas aeruginosa producing SPM metallo-β-lactamase. J Antimicrob Chemother. 2003;52(4):699–702.
   PubMed Web of Science ®Google Scholar
• Zavascki AP, Gaspareto PB, Martins AF, et al. Outbreak of carbapenem-resistant pseudomonas aeruginosa producing SPM-1 metallo-β-lactamase in a teaching hospital in southern Brazil. J Antimicrob Chemother. 2005;56(6):1148–1151.
   PubMed Web of Science ®Google Scholar
• Magalhaes V, Lins AK, Magalhaes M. Metallo-β-lactamase producing pseudomonas aeruginosa strains isolated in hospitals in Recife, PE, Brazil. Braz J Microbiol. 2005;36:123–125.
   Web of Science ®Google Scholar
• Viana Vieira V, Lourenço Da Fonseca E, Paulo VAC. Metallo-β-lactamases produced by carbapenem-resistant pseudomonas aeruginosa in Brazil. Clin Microbiol Infect. 2005;11(11):937.
   PubMed Web of Science ®Google Scholar
• Carvalho APD, Albano RM, De Oliveira DN, et al. Characterization of an epidemic carbapenem-resistant pseudomonas aeruginosa producing SPM-1 metallo-β-lactamase in a hospital located in Rio de Janeiro, Brazil. Microb Drug Resist. 2006;12(2):103–108.
   PubMed Web of Science ®Google Scholar
• Pellegrino FLPC, Casali N, Dos Santos KRN, et al. Pseudomonas aeruginosa epidemic strain carrying blaSPM metallo-beta-lactamase detected in Rio de Janeiro, Brazil. J Chemother. 2006;18(2):151–156.
   PubMed Web of Science ®Google Scholar
• Zavascki AP, Goldani LZ, Gonçalves ALS, et al. High prevalence of metallo-β-lactamase-mediated resistance challenging antimicrobial therapy against pseudomonas aeruginosa in a Brazilian teaching hospital. Epidemiol Infect. 2007;135(2):343–345.
   PubMed Web of Science ®Google Scholar
• Cipriano R, Vieira VV, Fonseca EL, et al. Coexistence of epidemic colistin-only-sensitive clones of pseudomonas aeruginosa, including the blaSPM clone, spread in hospitals in a Brazilian Amazon City. Microb Drug Resist. 2007;13(2):142–146.
   PubMed Web of Science ®Google Scholar
• Pellegrino FLPC, Casali N, Nouér SA, et al. A carbapenem-susceptible pseudomonas aeruginosa strain carrying the blaSPM gene. Diagn Microbiol Infect Dis. 2008;61(2):214–216.
   PubMed Web of Science ®Google Scholar
• Wirth FW, Picoli SU, Cantarelli VV, et al. Metallo-β-lactamase-producing pseudomonas aeruginosa in two hospitals from southern Brazil. Braz J Infect Dis. 2009;13(3):170–172.
   PubMed Web of Science ®Google Scholar
• Gonçalves DCPS, Lima ABM, Leão LSNDO, et al. Detection of metallo-beta-lactamase in pseudomonas aeruginosa isolated from hospitalized patients in Goiânia, State of Goiás. Rev Soc Bras Med Trop. 2009;42(4):411–414.
   PubMed Web of Science ®Google Scholar
• Jácome PRLDA, Alves LR, Cabral AB, et al. Phenotypic and molecular characterization of antimicrobial resistance and virulence factors in pseudomonas aeruginosa clinical isolates from Recife, State of Pernambuco, Brazil. Rev Soc Bras Med Trop. 2012;45(6):707–712.
   PubMed Web of Science ®Google Scholar
• De Oliveira RA, Gales AC, Da Silva RC, et al. Description and molecular characterization of metallo-β-lactamase SPM-1 in pseudomonas aeruginosa clinical strains from Goiânia, Brazil. Perspect Médicas. 2014;25(1):11–19.
   Google Scholar
• Barros EMLR, Morais VMS, Castro KCB, et al. First detection of metallo-β-lactamases in nosocomial isolates of pseudomonas aeruginosa in Alagoas, Brazil. J Bras Patol Med Lab. 2015;51(5):291–295.
   Google Scholar
• Costa LMDA, Fleming MEDCK, Paula GRD, et al. Production of metallo-β-lactamase among pseudomonas aeruginosa strains isolated in the State of Sergipe, Brazil. Rev Soc Bras Med Trop. 2015;48(2):212–215.
   PubMed Web of Science ®Google Scholar
• Fonseca ELD, Freitas FDS, Vicente ACP. The colistin-only-sensitive Brazilian pseudomonas aeruginosa clone SP (sequence type 277) is spread worldwide. Antimicrob Agents Chemother. 2010;54(6):2743.
   PubMed Web of Science ®Google Scholar
• Woodford N, Turton JF, Livermore DM. Multiresistant gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev. 2011;35(5):736–755.
   PubMed Web of Science ®Google Scholar
• Rossi F. The challenges of antimicrobial resistance in Brazil. Clin Infect Dis. 2011;52(9):1138–1143.
   PubMed Web of Science ®Google Scholar
• Andrade LN, Woodford N, Darini ALC. International gatherings and potential for global dissemination of São Paulo metallo-β-lactamase (SPM) from Brazil. Int J Antimicrob Agents. 2014;43(2):196–197.
   PubMed Web of Science ®Google Scholar
• Yong D, Toleman MA, Giske CG, et al. Characterization of a new metallo-β-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009;53(12):5046–5054.
   PubMed Web of Science ®Google Scholar
• Nordmann P, Poirel L, Walsh TR, et al. The emerging NDM carbapenemases. Trends Microbiol. 2011;19(12):588–595.
   PubMed Web of Science ®Google Scholar
• Pasteran F, Albornoz E, Faccone D, et al. Emergence of NDM-1-producing klebsiella pneumoniae in Guatemala. J Antimicrob Chemother. 2012;67(7):1795–1797.
   PubMed Web of Science ®Google Scholar
• Escobar Pérez JA, Olarte Escobar NM, Castro-Cardozo B, et al. Outbreak of NDM-1-producing klebsiella pneumoniae in a neonatal unit in Colombia. Antimicrob Agents Chemother. 2013;57(4):1957–1960.
   PubMed Web of Science ®Google Scholar
• Ovalle MV, Duarte C, Saavedra SY, et al. Circulación de carbapenemasas tipo New Delhi metalo-β-lactamasa (NDM), Colombia, 2011 a 2013. Inf Quinc Epidemiol Nac. 2013;18(11):122–132.
   Google Scholar
• Instituto Nacional de Salud. Circulación de carbapenemasas tipo Nueva Delhi metalo-β-lactamasa (NDM) en Colombia 2012-2014. Colombia:  Instituto Nacional de Salud. 2014.
   Google Scholar
• Saavedra-Rojas S-Y, Duarte-Valderrama C, González-de-Arias M-N, et al. Emergence of providencia rettgeri NDM-1 in two departments of Colombia, 2012-2013. Enferm Infecc Microbiol Clin. 2013. DOI:10.1016/j.eimc.2015.05.011
   Google Scholar
• Rojas LJ, Wright MS, De La Cadena E, et al. Initial assessment of the molecular epidemiology of blaNDM-1 in Colombia. Antimicrob Agents Chemother. 2016;60(7):4346–4350.
   PubMed Web of Science ®Google Scholar
• Pan American Health Organization (PAHO). Epidemiological alert: nosocomial transmission of NDM-type multiresistant bacteria. Washington, DC: Pan American Health Organization (PAHO). 2012 Dec 19.
   Google Scholar
• Seija V, Medina Presentado JC, Bado I, et al. Sepsis caused by New Delhi metallo-β-lactamase (blaNDM-1) and qnrD-producing Morganella morganii, treated successfully with fosfomycin and meropenem: case report and literature review. Int J Infect Dis. 2015;30:20–26.
   PubMed Web of Science ®Google Scholar
• Pasteran F, Mora MM, Albornoz E, et al. Emergence of genetically unrelated NDM-1-producing acinetobacter pittii strains in Paraguay. J Antimicrob Chemother. 2014;69(9):2575–2578.
   PubMed Web of Science ®Google Scholar
• Waterman PE, McGann P, Snesrud E, et al. Bacterial peritonitis due to acinetobacter baumannii sequence type 25 with plasmid-borne New Delhi metallo-β-lactamase in Honduras. Antimicrob Agents Chemother. 2013;57(9):4584–4586.
   PubMed Web of Science ®Google Scholar
• Barrios H, Garza-Ramos U, Reyna-Flores F, et al. Isolation of carbapenem-resistant NDM-1-positive providencia rettgeri in Mexico. J Antimicrob Chemother. 2013;68(8):1934–1936.
   PubMed Web of Science ®Google Scholar
• Barrios H, Silva-Sanchez J, Reyna-Flores F, et al. Detection of a NDM-1-producing klebsiella pneumoniae (ST22) clinical isolate at a pediatric hospital in Mexico. Pediatr Infect Dis J. 2014;33(3):335.
   PubMed Web of Science ®Google Scholar
• Torres-González P, Bobadilla-Del Valle M, Tovar-Calderón E, et al. Outbreak caused by enterobacteriaceae harboring NDM-1 metallo-β-lactamase carried in an IncFII plasmid in a tertiary care hospital in Mexico city. Antimicrob Agents Chemother. 2015;59(11):7080–7083.
   PubMed Web of Science ®Google Scholar
• Carvalho-Assef APD, Pereira PS, Albano RM, et al. Isolation of NDM-producing providencia rettgeri in Brazil. J Antimicrob Chemother. 2013;68(12):2956–2957.
   PubMed Web of Science ®Google Scholar
• Carvalho-Assef APD, Pereira PS, Albano RM, et al. Detection of NDM-1-, CTX-M-15-, and qnrB4-producing enterobacter hormaechei isolates in Brazil. Antimicrob Agents Chemother. 2014;58(4):2475–2476.
   PubMed Web of Science ®Google Scholar
• Rozales FP, Ribeiro VB, Magagnin CM, et al. Emergence of NDM-1-producing enterobacteriaceae in Porto Alegre, Brazil. Int J Infect Dis. 2014;25:79–81.
   PubMed Web of Science ®Google Scholar
• Carneiro M, Gonçalves RA, De Souza JG, et al. New carbapenases in Brazil. Expert Rev Anti Infect Ther. 2014;12(2):155–156.
   PubMed Web of Science ®Google Scholar
• Carmo Junior NVD, Filho HF, Gomes E Costa DA, et al. First report of a NDM-producing providencia rettgeri strain in the state of São Paulo. Braz J Infect Dis. 2015;19(6):675–676.
   PubMed Web of Science ®Google Scholar
• Andrade LN, Darini ALC. Response to detection of New Delhi metallo-β-lactamase-producing bacteria, Brazil. Emerg Infect Dis. 2015;21(6):1069–1071.
   PubMed Web of Science ®Google Scholar
• Quiles MG, Rocchetti TT, Fehlberg LC, et al. Unusual association of NDM-1 with KPC-2 and armA among Brazilian enterobacteriaceae isolates. Braz J Med Biol Res. 2015;48(2):174–177.
   PubMed Web of Science ®Google Scholar
• Pereira PS, Borghi M, Albano RM, et al. Coproduction of NDM-1 and KPC-2 in enterobacter hormaechei from Brazil. Microb Drug Resist. 2015;21(2):234–236.
   PubMed Web of Science ®Google Scholar
• Pillonetto M, Arend L, Vespero EC, et al. First report of NDM-1-producing acinetobacter baumannii sequence type 25 in Brazil. Antimicrob Agents Chemother. 2014;58(12):7592–7594.
   PubMed Web of Science ®Google Scholar
• Pagano M, Poirel L, Martins AF, et al. Emergence of NDM-1-producing acinetobacter pittii in Brazil. Int J Antimicrob Agents. 2015;45(4):444–445.
   PubMed Web of Science ®Google Scholar
• Pasteran F, Meo A, Gomez S, et al. Emergence of genetically related NDM-1-producing providencia rettgeri strains in Argentina. J Glob Antimicrob Resist. 2014;2(4):344–345.
   PubMed Web of Science ®Google Scholar
• Montaña S, Cittadini R, Del Castillo M, et al. Presence of New Delhi metallo-β-lactamase gene (NDM-1) in a clinical isolate of acinetobacter junii in Argentina. New Microbes New Infect. 2016;11:43–44.
   PubMedGoogle Scholar
• Pan American Health Organization (PAHO) /World Health Organization (WHO). Epidemiological update. Carbapenemases of type New Delhi metallo-β-lactamase (NDM). Washington, DC: Pan American Health Organization (PAHO). 2014 Mar 7.
   Google Scholar
• Quiñones D, Carvajal I, Perez Y, et al. High prevalence of blaOXA-23 in acinetobacter spp. and detection of blaNDM-1 in A. soli in Cuba: report from national surveillance program (2010-2012). New Microbes New Infect. 2015;7:52–56.
   PubMedGoogle Scholar
• Thoms-Rodriguez C-A, Mazzulli T, Christian N, et al. New Delhi metallo-β-lactamase in Jamaica. J Infect Dev Ctries. 2016;10(2):183–187.
   PubMed Web of Science ®Google Scholar
• Bastian S, Nordmann P, Creton E, et al. First case of NDM-1 producing klebsiella pneumoniae in Caribbean islands. Int J Infect Dis. 2015;34:53–54.
   PubMed Web of Science ®Google Scholar
• Delgado-Blas JF, Ovejero CM, Abadia-Patiño L, et al. Coexistence of mcr-1 and blaNDM-1 in escherichia coli from Venezuela. Antimicrob Agents Chemother. 2016;60(10):6356–6358.
   PubMed Web of Science ®Google Scholar
• Poirel L, Naas T, Nordmann P. Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrob Agents Chemother. 2010;54(1):24–38.
   PubMed Web of Science ®Google Scholar
• Evans BA, Amyes SGB. OXA β-lactamases. Clin Microbiol Rev. 2014;27(2):241–263.
   PubMed Web of Science ®Google Scholar
• Mugnier PD, Poirel L, Naas T, et al. Worldwide dissemination of the blaOXA-23 carbapenemase gene of acinetobacter baumannii. Emerg Infect Dis. 2010;16(1):35–40.
   PubMed Web of Science ®Google Scholar
• Turton JF, Ward ME, Woodford N, et al. The role of ISAba1 in expression of OXA carbapenemase genes in acinetobacter baumannii. FEMS Microbiol Lett. 2006;258(1):72–77.
   PubMed Web of Science ®Google Scholar
• Paton R, Miles RS, Hood J, et al. ARI 1: β-lactamase-mediated imipenem resistance in acinetobacter baumannii. Int J Antimicrob Agents. 1993;2(2):81–87.
   PubMedGoogle Scholar
• Donald HM, Scaife W, Amyes SG, et al. Sequence analysis of ARI-1, a novel OXA β-lactamase, responsible for imipenem resistance in acinetobacter baumannii 6B92. Antimicrob Agents Chemother. 2000;44(1):196–199.
   PubMed Web of Science ®Google Scholar
• Scaife W, Young HK, Paton RH, et al. Transferable imipenem-resistance in acinetobacter species from a clinical source. J Antimicrob Chemother. 1995;36(3):585–586.
   PubMed Web of Science ®Google Scholar
• Bonnet R, Marchandin H, Chanal C, et al. Chromosome-encoded class D β-lactamase OXA-23 in proteus mirabilis. Antimicrob Agents Chemother. 2002;46(6):2004–2006.
   PubMed Web of Science ®Google Scholar
• Dalla-Costa LM, Coelho JM, Souza HAPHM, et al. Outbreak of carbapenem-resistant acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J Clin Microbiol. 2003;41(7):3403–3406.
   PubMed Web of Science ®Google Scholar
• Carvalho KR, Carvalho-Assef APD, Peirano G, et al. Dissemination of multidrug-resistant acinetobacter baumannii genotypes carrying blaOXA-23 collected from hospitals in Rio de Janeiro, Brazil. Int J Antimicrob Agents. 2009;34(1):25–28.
   PubMed Web of Science ®Google Scholar
• Martins AF, Kuchenbecker R, Sukiennik T, et al. Carbapenem-resistant acinetobacter baumannii producing the OXA-23 enzyme: dissemination in Southern Brazil. Infection. 2009;37(5):474–476.
   PubMed Web of Science ®Google Scholar
• Schimith Bier KE, Luiz SO, Scheffer MC, et al. Temporal evolution of carbapenem-resistant acinetobacter baumannii in Curitiba, southern Brazil. Am J Infect Control. 2010;38(4):308–314.
   PubMed Web of Science ®Google Scholar
• Antonio CS, Neves PR, Medeiros M, et al. High prevalence of carbapenem-resistant acinetobacter baumannii carrying the blaOXA-143 gene in Brazilian hospitals. Antimicrob Agents Chemother. 2011;55(3):1322–1323.
   PubMed Web of Science ®Google Scholar
• Werneck JS, Picão RC, Girardello R, et al. Low prevalence of blaOXA-143 in private hospitals in Brazil. Antimicrob Agents Chemother. 2011;55(9):4494–4495.
   PubMed Web of Science ®Google Scholar
• Grosso F, Carvalho KR, Quinteira S, et al. OXA-23-producing acinetobacter baumannii: a new hotspot of diversity in Rio de Janeiro? J Antimicrob Chemother. 2011;66(1):62–65.
   PubMed Web of Science ®Google Scholar
• Figueiredo DQD, Santos KRND, Pereira EM, et al. First report of the blaOXA-58 gene in a clinical isolate of acinetobacter baumannii in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz. 2011;106(3):368–370.
   PubMed Web of Science ®Google Scholar
• Corrêa LL, Botelho LAB, Barbosa LC, et al. Detection of blaOXA-23 in acinetobacter spp. isolated from patients of a university hospital. Braz J Infect Dis. 2012;16(6):521–526.
   PubMed Web of Science ®Google Scholar
• Martins AF, Kuchenbecker RS, Pilger KO, et al. High endemic levels of multidrug-resistant acinetobacter baumannii among hospitals in southern Brazil. Am J Infect Control. 2012;40(2):108–112.
   PubMed Web of Science ®Google Scholar
• Fonseca EL, Scheidegger E, Freitas FS, et al. Carbapenem-resistant acinetobacter baumannii from Brazil: role of carO alleles expression and blaOXA-23 gene. BMC Microbiol. 2013;13(1):245.
   PubMed Web of Science ®Google Scholar
• Martins N, Martins IS, De Freitas WV, et al. Imported and intensive care unit-born acinetobacter baumannii clonal complexes: one-year prospective cohort study in intensive care patients. Microb Drug Resist. 2013;19(3):216–223.
   PubMed Web of Science ®Google Scholar
• Clímaco EC, Oliveira ML, De, Pitondo-Silva A, et al. Clonal complexes 104, 109 and 113 playing a major role in the dissemination of OXA-carbapenemase-producing acinetobacter baumannii in Southeast Brazil. Infect Genet Evol. 2013;19:127–133.
   PubMed Web of Science ®Google Scholar
• Chagas TPG, Carvalho KR, De Oliveira Santos IC, et al. Characterization of carbapenem-resistant acinetobacter baumannii in Brazil (2008-2011): countrywide spread of OXA-23-producing clones (CC15 and CC79). Diagn Microbiol Infect Dis. 2014;79(4):468–472.
   PubMed Web of Science ®Google Scholar
• Vasconcelos ATR, Barth AL, Zavascki AP, et al. The changing epidemiology of acinetobacter spp. producing OXA carbapenemases causing bloodstream infections in Brazil: a BrasNet report. Diagn Microbiol Infect Dis. 2015;83(4):382–385.
   PubMed Web of Science ®Google Scholar
• Dias VC, Diniz CG, Peter ACDO, et al. Epidemiological characteristics and antimicrobial susceptibility among carbapenem-resistant non-fermenting bacteria in Brazil. J Infect Dev Ctries. 2016;10(6):544–553.
   PubMed Web of Science ®Google Scholar
• Teixeira AB, Martins AF, Barin J, et al. First report of carbapenem-resistant acinetobacter nosocomialis isolates harboring ISAba1-blaOXA-23 genes in Latin America. J Clin Microbiol. 2013;51(8):2739–2741.
   PubMed Web of Science ®Google Scholar
• Carvalho KR, Carvalho-Assef APD, Santos LGD. Occurrence of blaOXA-23 gene in imipenem-susceptible acinetobacter baumannii. Mem Inst Oswaldo Cruz. 2011;106(4):505–506.
   PubMed Web of Science ®Google Scholar
• Merkier AK, Catalano M, Ramírez MS, et al. Polyclonal spread of blaOXA-23 and blaOXA-58 in acinetobacter baumannii isolates from Argentina. J Infect Dev Ctries. 2008;2(3):235–240.
   PubMed Web of Science ®Google Scholar
• Merkier AK, Centrón D. blaOXA-51-type β-lactamase genes are ubiquitous and vary within a strain in acinetobacter baumannii. Int J Antimicrob Agents. 2006;28(2):110–113.
   PubMed Web of Science ®Google Scholar
• Stietz MS, Ramírez MS, Vilacoba E, et al. Acinetobacter baumannii extensively drug resistant lineages in Buenos Aires hospitals differ from the international clones I-III. Infect Genet Evol. 2013;14(1):294–301.
   PubMed Web of Science ®Google Scholar
• Rodriguez CH, Balderrama Yarhui N, Nastro M, et al. Molecular epidemiology of carbapenem-resistant acinetobacter baumannii in South America. J Med Microbiol. 2016. DOI:10.1099/jmm.0.000328
   PubMed Web of Science ®Google Scholar
• Cuaical Ramos NM, Delgado Borrero YA, Anzola Anzola YM, et al. Detection of OXA type carbapenemases in acinetobacter baumannii from different hospital centers in Caracas, Venezuela. Rev Soc Ven Microbiol. 2012;32(2):95–100.
   Google Scholar
• Villegas MV, Kattan JN, Correa A, et al. Dissemination of acinetobacter baumannii clones with OXA-23 carbapenemase in Colombian hospitals. Antimicrob Agents Chemother. 2007;51(6):2001–2004.
   PubMed Web of Science ®Google Scholar
• Pinzon JO, Mantilla JR, Valenzuela EM, et al. Molecular characterization of acinetobacter baumannii isolations from a burns unit in a third level attention hospital in Bogotá. Infectio. 2006;10(2):71–78.
   Google Scholar
• Saavedra SY, Nuñez JC, Pulido IY, et al. Characterisation of carbapenem-resistant acinetobacter calcoaceticus-A. baumannii complex isolates in a third-level hospital in Bogotá, Colombia. Int J Antimicrob Agents. 2008;31(4):389–391.
   PubMed Web of Science ®Google Scholar
• Saavedra-Trujillo CH, Arias-León G, Gualtero-Trujillo SM, et al. Risk factors for colonisation or infection by Acinetobacter baumannii resistant to carbapenems in adult patients hospitalised in intensive care units in Bogota, Colombia. Infectio. 2016;20(4):238–249.
   Google Scholar
• Martínez P, Mattar S. Imipenem-resistant acinetobacter baumannii carrying the ISAba1-blaOXA-23,51 and ISAba1-blaADC-7 genes in Monteria, Colombia. Braz J Microbiol. 2012;43(4):1274–1280.
   PubMed Web of Science ®Google Scholar
• Vanegas JM, Higuita LF, Vargas CA, et al. Carbapenem-resistant acinetobacter baumannii causing osteomyelitis and infections of skin and soft tissues in hospitals of Medellín, Colombia. Biomedica. 2015;35(4):522–530.
   PubMed Web of Science ®Google Scholar
• Correa A, Del Campo R, Escandón-Vargas K, et al. Distinct genetic diversity of carbapenem-resistant Acinetobacter baumannii from Colombian hospitals. Microb Drug Resist. 2016.
   Google Scholar
• Reguero MT, Medina OE, Hernández MA, et al. Antibiotic resistance patterns of acinetobacter calcoaceticus-A. baumannii complex species from Colombian hospitals. Enferm Infecc Microbiol Clin. 2013;31(3):142–146.
   PubMed Web of Science ®Google Scholar
• Opazo A, Bello H, Dominguez M, et al. First report of blaOXA-23 in acinetobacter baumannii isolates from Chilean hospitals. J Glob Antimicrob Resist. 2015;3(1):54–55.
   PubMed Web of Science ®Google Scholar
• Thoms-Rodriguez C-A, Nicholson A, Christian N, et al. The detection of the NDM-1 and other carbapenemase genes in multidrug resistant gram negative bacilli (MDRGNB) in a Jamaican hospital. Int J Infect Dis. 2012;16(2):e434–e435.
   Web of Science ®Google Scholar
• Tamayo-Legorreta EM, Garza-Ramos U, Barrios-Camacho H, et al. Identification of OXA-23 carbapenemases: novel variant OXA-239 in acinetobacter baumannii ST758 clinical isolates in Mexico. New Microbes New Infect. 2014;2(6):173–174.
   PubMedGoogle Scholar
• Gonzalez-Villoria AM, Tamayo-Legorreta E, Garza-Ramos U, et al. A multicenter study in Mexico finds acinetobacter baumannii clinical isolates belonging to clonal complexes 636B (113B) and 92B harboring OXA-72, OXA-239, and OXA-469. Antimicrob Agents Chemother. 2016;60(4):2587–2588.
   PubMed Web of Science ®Google Scholar
• Nuñez Quezada T, Rodríguez CH, Castro Cañarte G, et al. Outbreak of blaOXA-72-producing acinetobacter baumannii in South America. J Chemother. 2016. DOI:10.1080/1120009X.2016.1158936
   PubMedGoogle Scholar
• Sennati S, Villagran AL, Bartoloni A, et al. OXA-23-producing ST25 acinetobacter baumannii: first report in Bolivia. J Glob Antimicrob Resist. 2016;4:70–71.
   PubMed Web of Science ®Google Scholar
• Karah N, Sundsfjord A, Towner K, et al. Insights into the global molecular epidemiology of carbapenem non-susceptible clones of acinetobacter baumannii. Drug Resist Updat. 2012;15(4):237–247.
   PubMed Web of Science ®Google Scholar
• Bou G, Oliver A, Martínez-Beltrán J. OXA-24, a novel class D β-lactamase with carbapenemase activity in an acinetobacter baumannii clinical strain. Antimicrob Agents Chemother. 2000;44(6):1556–1561.
   PubMed Web of Science ®Google Scholar
• Mendes RE, Castanheira M, Deshpande LM, et al. Rapid emergence and spread of Acinetobacter spp. producing carbapenem-hydrolyzing oxacillinases: report from the SENTRY program. 48th ICAAC/46th IDSA. Washington, DC, USA: American Society for Microbiology (ASM) and Infectious Diseases Society of America (IDSA). 2008. p. Abstract C2–3857.
   Google Scholar
• Bocanegra-Ibarias P, Peña-López C, Camacho-Ortiz A, et al. Genetic characterisation of drug resistance and clonal dynamics of acinetobacter baumannii in a hospital setting in Mexico. Int J Antimicrob Agents. 2015;45(3):309–313.
   PubMed Web of Science ®Google Scholar
• Werneck JS, Picão RC, Carvalhaes CG, et al. OXA-72-producing acinetobacter baumannii in Brazil: a case report. J Antimicrob Chemother. 2011;66(2):452–454.
   PubMed Web of Science ®Google Scholar
• De Sá Cavalcanti FL, Almeida ACS, Vilela MA, et al. Emergence of extensively drug-resistant OXA-72-producing acinetobacter baumannii in Recife, Brazil: risk of clonal dissemination? Diagn Microbiol Infect Dis. 2013;77(3):250–251.
   PubMed Web of Science ®Google Scholar
• Montealegre MC, Maya JJ, Correa A, et al. First identification of OXA-72 carbapenemase from acinetobacter pittii in Colombia. Antimicrob Agents Chemother. 2012;56(7):3996–3998.
   PubMed Web of Science ®Google Scholar
• Saavedra SY, Cayô R, Gales AC, et al. Early dissemination of OXA-72-producing acinetobacter baumannii strain in Colombia: a case report. Braz J Infect Dis. 2014;18(6):678–680.
   PubMed Web of Science ®Google Scholar
• Brown S, Young HK, Amyes SGB. Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of acinetobacter baumannii from Argentina. Clin Microbiol Infect. 2005;11(1):15–23.
   PubMed Web of Science ®Google Scholar
• Coelho J, Woodford N, Afzal-Shah M, et al. Occurrence of OXA-58-like carbapenemases in acinetobacter spp. collected over 10 years in three continents. Antimicrob Agents Chemother. 2006;50(2):756–758.
   PubMed Web of Science ®Google Scholar
• Fernández Colón E, Bustamante García Z, Zamora Balderrama J, et al. Determining carbapenemases and its relationship to genetic structures in clinical isolates of acinetobacter baumannii at hospitals in the city of Cochabamba. Biofarbo. 2009;17(1):30–38.
   Google Scholar
• Sevillano E, Fernández E, Bustamante Z, et al. Emergence and clonal dissemination of carbapenem-hydrolysing OXA-58-producing acinetobacter baumannii isolates in Bolivia. J Med Microbiol. 2012;61(Pt 1):80–84.
   PubMed Web of Science ®Google Scholar
• Higgins PG, Pérez-Llarena FJ, Zander E, et al. OXA-235, a novel class D β-lactamase involved in resistance to carbapenems in acinetobacter baumannii. Antimicrob Agents Chemother. 2013;57(5):2121–2126.
   PubMed Web of Science ®Google Scholar
• Hamouda A, Evans BA, Towner KJ, et al. Characterization of epidemiologically unrelated acinetobacter baumannii isolates from four continents by use of multilocus sequence typing, pulsed-field gel electrophoresis, and sequence-based typing of blaOXA-51-like genes. J Clin Microbiol. 2010;48(7):2476–2483.
   PubMed Web of Science ®Google Scholar
• Figueiredo S, Poirel L, Papa A, et al. Overexpression of the naturally occurring blaOXA-51 gene in acinetobacter baumannii mediated by novel insertion sequence ISAba9. Antimicrob Agents Chemother. 2009;53(9):4045–4047.
   PubMed Web of Science ®Google Scholar
• Héritier C, Poirel L, Fournier P-E, et al. Characterization of the naturally occurring oxacillinase of acinetobacter baumannii. Antimicrob Agents Chemother. 2005;49(10):4174–4179.
   PubMed Web of Science ®Google Scholar
• Poirel L, Marqué S, Héritier C, et al. OXA-58, a novel class D β-lactamase involved in resistance to carbapenems in acinetobacter baumannii. Antimicrob Agents Chemother. 2005;49(1):202–208.
   PubMed Web of Science ®Google Scholar
• Cayô R, Rodrigues-Costa F, Pereira Matos A, et al. Old clinical isolates of acinetobacter seifertii in Brazil producing OXA-58. Antimicrob Agents Chemother. 2016;60(4):2589–2591.
   PubMed Web of Science ®Google Scholar
• Salazar De Vegas EZ, Nieves B, Ruiz M, et al. Molecular epidemiology and characterization of resistance mechanisms to various antimicrobial agents in acinetobacter baumannii isolated in Mérida, Venezuela. Med Sci Monit. 2007;13(4):BR89–94.
   PubMed Web of Science ®Google Scholar
• Poirel L, Héritier C, Tolün V, et al. Emergence of oxacillinase-mediated resistance to imipenem in klebsiella pneumoniae. Antimicrob Agents Chemother. 2004;48(1):15–22.
   PubMed Web of Science ®Google Scholar
• Lascols C, Peirano G, Hackel M, et al. Surveillance and molecular epidemiology of klebsiella pneumoniae isolates that produce carbapenemases: first report of OXA-48-like enzymes in North America. Antimicrob Agents Chemother. 2013;57(1):130–136.
   PubMed Web of Science ®Google Scholar
• Vanegas JM, Ospina WP, Higuita-Gutiérrez LF, et al. First reported case of an OXA-48-producing isolate from a Colombian patient. J Glob Antimicrob Resist. 2016;6:67–68.
   PubMed Web of Science ®Google Scholar
• Poirel L, Castanheira M, Carrër A, et al. OXA-163, an OXA-48-related class D β-lactamase with extended activity toward expanded-spectrum cephalosporins. Antimicrob Agents Chemother. 2011;55(6):2546–2551.
   PubMed Web of Science ®Google Scholar
• Gomez S, Pasteran F, Faccone D, et al. Intrapatient emergence of OXA-247: a novel carbapenemase found in a patient previously infected with OXA-163-producing klebsiella pneumoniae. Clin Microbiol Infect. 2013;19(5):E233–5.
   PubMed Web of Science ®Google Scholar
• Sampaio JLM, Ribeiro VB, Campos JC, et al. Detection of OXA-370, an OXA-48-related class D β-lactamase, in enterobacter hormaechei from Brazil. Antimicrob Agents Chemother. 2014;58(6):3566–3567.
   PubMed Web of Science ®Google Scholar
• Pereira PS, Borghi M, De Araújo CFM, et al. Clonal dissemination of OXA-370-producing klebsiella pneumoniae in Rio de Janeiro, Brazil. Antimicrob Agents Chemother. 2015;59(8):4453–4456.
   PubMed Web of Science ®Google Scholar
• Higgins PG, Poirel L, Lehmann M, et al. OXA-143, a novel carbapenem-hydrolyzing class D β-lactamase in acinetobacter baumannii. Antimicrob Agents Chemother. 2009;53(12):5035–5038.
   PubMed Web of Science ®Google Scholar
• Gionco B, Pelayo JS, Venancio EJ, et al. Detection of OXA-231, a new variant of blaOXA-143, in acinetobacter baumannii from Brazil: a case report. J Antimicrob Chemother. 2012;67(10):2531–2532.
   PubMed Web of Science ®Google Scholar
• Zander E, Bonnin RA, Seifert H, et al. Characterization of blaOXA-143 variants in acinetobacter baumannii and acinetobacter pittii. Antimicrob Agents Chemother. 2014;58(5):2704–2708.
   PubMed Web of Science ®Google Scholar
• Girlich D, Damaceno QS, Oliveira AC, et al. OXA-253, a variant of the carbapenem-hydrolyzing class D β-lactamase OXA-143 in Acinetobacter baumannii. Antimicrob Agents Chemother. 2014;58(5):2976–2976.
   PubMed Web of Science ®Google Scholar